202 related articles for article (PubMed ID: 21912327)
1. Performance of different population pharmacokinetic algorithms.
Colucci P; Grenier J; Yue CS; Turgeon J; Ducharme MP
Ther Drug Monit; 2011 Oct; 33(5):583-91. PubMed ID: 21912327
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the nonparametric estimation method in NONMEM VI.
Savic RM; Kjellsson MC; Karlsson MO
Eur J Pharm Sci; 2009 Apr; 37(1):27-35. PubMed ID: 19159684
[TBL] [Abstract][Full Text] [Related]
3. Fisher information matrix for nonlinear mixed effects multiple response models: evaluation of the appropriateness of the first order linearization using a pharmacokinetic/pharmacodynamic model.
Bazzoli C; Retout S; Mentré F
Stat Med; 2009 Jun; 28(14):1940-56. PubMed ID: 19266541
[TBL] [Abstract][Full Text] [Related]
4. Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.
Bustad A; Terziivanov D; Leary R; Port R; Schumitzky A; Jelliffe R
Clin Pharmacokinet; 2006; 45(4):365-83. PubMed ID: 16584284
[TBL] [Abstract][Full Text] [Related]
5. Performance comparison of first-order conditional estimation with interaction and Bayesian estimation methods for estimating the population parameters and its distribution from data sets with a low number of subjects.
Pradhan S; Song B; Lee J; Chae JW; Kim KI; Back HM; Han N; Kwon KI; Yun HY
BMC Med Res Methodol; 2017 Dec; 17(1):154. PubMed ID: 29191177
[TBL] [Abstract][Full Text] [Related]
6. A two-step iterative algorithm for estimation in nonlinear mixed-effect models with an evaluation in population pharmacokinetics.
Mentré F; Gomeni R
J Biopharm Stat; 1995 Jul; 5(2):141-58. PubMed ID: 7581424
[TBL] [Abstract][Full Text] [Related]
7. A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples.
Bauer RJ; Guzy S; Ng C
AAPS J; 2007 Mar; 9(1):E60-83. PubMed ID: 17408237
[TBL] [Abstract][Full Text] [Related]
8. Comparing the performance of FOCE and different expectation-maximization methods in handling complex population physiologically-based pharmacokinetic models.
Liu X; Wang Y
J Pharmacokinet Pharmacodyn; 2016 Aug; 43(4):359-70. PubMed ID: 27215925
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous versus sequential pharmacokinetic-pharmacodynamic population analysis using an iterative two-stage Bayesian technique.
Proost JH; Schiere S; Eleveld DJ; Wierda JM
Biopharm Drug Dispos; 2007 Nov; 28(8):455-73. PubMed ID: 17847121
[TBL] [Abstract][Full Text] [Related]
10. Fast 3D iterative image reconstruction for SPECT with rotating slat collimators.
Holen RV; Vandenberghe S; Staelens S; De Beenhouwer J; Lemahieu I
Phys Med Biol; 2009 Feb; 54(3):715-29. PubMed ID: 19131666
[TBL] [Abstract][Full Text] [Related]
11. The bayesian bias correction method of the first-order approximation of nonlinear mixed-effects models for population pharmacokinetics.
Funatogawa T; Funatogawa I
J Biopharm Stat; 2007; 17(3):381-92. PubMed ID: 17479388
[TBL] [Abstract][Full Text] [Related]
12. Approaches to handling pharmacodynamic baseline responses.
Dansirikul C; Silber HE; Karlsson MO
J Pharmacokinet Pharmacodyn; 2008 Jun; 35(3):269-83. PubMed ID: 18446428
[TBL] [Abstract][Full Text] [Related]
13. Nonlinear mixed effects to improve glucose minimal model parameter estimation: a simulation study in intensive and sparse sampling.
Denti P; Bertoldo A; Vicini P; Cobelli C
IEEE Trans Biomed Eng; 2009 Sep; 56(9):2156-66. PubMed ID: 19380266
[TBL] [Abstract][Full Text] [Related]
14. Correction of photon attenuation and collimator response for a body-contouring SPECT/CT imaging system.
Seo Y; Wong KH; Sun M; Franc BL; Hawkins RA; Hasegawa BH
J Nucl Med; 2005 May; 46(5):868-77. PubMed ID: 15872362
[TBL] [Abstract][Full Text] [Related]
15. Population one-compartment pharmacokinetic analysis with missing dosage data.
Soy D; Beal SL; Sheiner LB
Clin Pharmacol Ther; 2004 Nov; 76(5):441-51. PubMed ID: 15536459
[TBL] [Abstract][Full Text] [Related]
16. Hyperparameter estimation using stochastic approximation with application to population pharmacokinetics.
Mentré F; Mallet A; Steimer JL
Biometrics; 1988 Sep; 44(3):673-83. PubMed ID: 3203126
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic parameters estimation using adaptive Bayesian P-splines models.
Jullion A; Lambert P; Beck B; Vandenhende F
Pharm Stat; 2009; 8(2):98-112. PubMed ID: 18481279
[TBL] [Abstract][Full Text] [Related]
18. Revisiting FDA's 1995 Guidance on Bioequivalence Establishment of Topical Dermatologic Corticosteroids: New Research Based Recommendations.
Ozdin D; Sharma N; Lujan-Zilbermann J; Colucci P; Kanfer I; Ducharme MP
J Pharm Pharm Sci; 2018; 21(1):413-428. PubMed ID: 30407906
[TBL] [Abstract][Full Text] [Related]
19. [Using CTS and PK-PD models to predict the effect of uncertainty about population parameters on clinical trial power].
Zhu L; Shi X; Liu Y
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Feb; 26(1):42-6, 62. PubMed ID: 19334551
[TBL] [Abstract][Full Text] [Related]
20. An implementation of the Expectation-Maximisation (EM) algorithm for population pharmacokinetic-pharmacodynamic modelling in ACSLXTREME.
Yates JW
Comput Methods Programs Biomed; 2009 Oct; 96(1):49-62. PubMed ID: 19410328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
